The business of health care in America is deeply out of whack.
Big Pharma
Posted inHealth and Social Policy
Pharma Giants Block Access to Vaccine Doses for Research
Pfizer and Moderna are preventing scientists from using their current vaccines for research. The U.S. should act now to restore competition.
Posted inHealth and Social Policy
The Post-Ozempic Gold Rush
So much energy is going into developing effective weight loss pills, while hundreds of lifesaving medications remain in shortage.
Posted inHealth and Social Policy
The Obscure NIH Official Blocking Lower Drug Prices
Mark Rohrbaugh, a mid-level staffer at the National Institutes of Health, has consistently blocked the use of march-in rights to seize patents on high-cost drugs.
Posted inHealth and Social Policy
Merck Says Negotiating Drug Prices Is Unconstitutional
The Inflation Reduction Act took minor steps against Big Pharma price-gouging. Merck is outraged.
Posted inHealth and Social Policy
How Big Pharma Rigged the Patent System
Drug patents are supposed to expire in 20 years. Thanks to legal trickery, though, it usually takes a lot longer than that.
Posted inHealth and Social Policy
Regulators on the Verge of Bungling Drug Price Reform, Advocates Say
The starting point for negotiations with drug companies on prescription prices could end up being the too-high prices patients already live with.
Posted inEconomic Policy
Drug Shortages as an Indictment of Capitalism
Here is a vital sector of the economy crying out for socialized production and distribution.
Posted inMoney, Politics, and Power
Pharma Cash Built the Conservative Court Majority That Now Harms Pharma
Drug industry CEOs angrily dispute Judge Matthew Kacsmaryk’s ruling on mifepristone. But they spent millions on the Senate Republicans who confirmed him.
Posted inHealth and Social Policy
India Decides Fighting Tuberculosis Is More Important Than Johnson & Johnson’s Profits
The country shot down a patent extension on a critical TB drug.
